Acasti pharma provides update following acquisition of grace therapeutics and regains compliance with nasdaq listing standards

Laval, quÉbec, sept. 22, 2021 (globe newswire) -- acasti pharma inc. (“acasti” or the “company”) (nasdaq: acst and tsx-v: acst), today provided a business update and announced that the nasdaq stock market (“nasdaq”) has confirmed to acasti that the company has regained compliance with nasdaq's minimum bid price requirement.
ACST Ratings Summary
ACST Quant Ranking